NIH SBIR Grant Awarded to Accelerate Magnetic Particle Imaging in Cancer Immunology
During the twelve-month project, entitled "Development of a commercial Magnetic Particle Imaging platform for the detection and quantification of localized inflammation in cancer," Magnetic Insight will develop new cancer immunology tools for visualizing inflammation.
- During the twelve-month project, entitled "Development of a commercial Magnetic Particle Imaging platform for the detection and quantification of localized inflammation in cancer," Magnetic Insight will develop new cancer immunology tools for visualizing inflammation.
- Localized inflammation is an attractive diagnostic imaging target for a variety of diseases and conditions, including traumatic injury, stroke, auto-immune diseases, and cancer.
- "Magnetic particle imaging is enabling new insights into cancer immunology by tracking therapeutic cells, identifying inflammation due to immune activation, and with targeted hyperthermia.
- Magnetic Particle Imaging (MPI) is an ultrasensitive, safe, and quantitative technology built on high-contrast detection of iron-oxide nanoparticles.